Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Creative Enzymes Introduces Detergent Enzyme Blend Granule for Effective Stain Removal

    Apr 6, 2023, 10:32 AM by
    Full story
  • Creative Enzymes Launches Revolutionary Enzyme for Toothpaste to Improve Oral Health

    Apr 6, 2023, 10:18 AM by
    Full story
  • Ex-Komodo Health VP, Vivian DeWoskin, Joins NeuraLight As Chief Commercial Officer

    Apr 6, 2023, 10:17 AM by
    Full story
  • Synapse Biomedical Wins New Approval for Diaphragm Pacing System to Free Patients from Ventilators

    Apr 6, 2023, 10:17 AM by
    Synapse Biomedical Wins New Approval for Diaphragm Pacing System to Free Patients from Ventilators
    Full story
  • Global Collaboration Enables Headway On Rare Neuroendocrine Tumors

    Apr 6, 2023, 01:00 AM by User Not Found
    Bio-IT World | Researchers in Madrid recently wrapped up the largest-yet genomic study of rare neuroendocrine tumors, known as pheochromocytomas and paragangliomas, which identified a seemingly perfect panel of metastatic disease markers as well as a group of patients who could potentially benefit from immunotherapy. The objective here is a better means to predict, at the time of diagnosis of the primary tumor, whether patients will be immediately affected by cancer spread.
    Full story
  • Intermountain Health Expands Relationship with Kyruus to Create Foundation for Rebranded Digital Experience

    Apr 5, 2023, 11:06 AM by
    Intermountain Health just announced that they are expanding use of the Kyruus’ ProviderMatch® platform to power a new digital patient experience initiative. This engagement builds on an existing relationship with Kyruus via legacy SCL Health (now Intermountain) in which Kyruus overhauled the system’s provider directory and replaced its existing online scheduling solution, which in less than a year, yielded a 21% increase in appointments scheduled online.
    Full story
  • CluePoints Announces Amit Patel as New CFO

    Apr 5, 2023, 11:05 AM by
    CluePoints Announces Amit Patel as New CFO Organizational changes support rapid growth, scale, and focus for RBQM leader
    Full story
  • Greenphire Appoints Steve Geffon as Chief Commercial Officer

    Apr 5, 2023, 11:05 AM by
    New CCO to lead global go-to-market strategy as the company prepares to introduce a new era of innovation for the clinical trial industry
    Full story
  • Bora Pharmaceuticals and Celltrion partner to expand OSD capabilities in APAC market

    Apr 5, 2023, 11:04 AM by
    Full story
  • Custom Stainless Enclosures Highlights 4Xxtreme® Double Seal Enclosures™

    Apr 5, 2023, 11:02 AM by
    About Custom Stainless Enclosures Custom Stainless Enclosures, Inc. is an innovation leading manufacturer of electrical enclosures for the food, pharmaceutical, oil and gas, and wastewater industries, among others. Custom Stainless Enclosures is the proud manufacturer of 4Xxtreme® Enclosures – the newest innovation in the electrical enclosure industry. For the past ten years, Custom Stainless Enclosures has dedicated its time, knowledge, and effort to developing a revolutionary product that will change the way the industry views electrical enclosures. Visit https://4xxtreme.com/ or call (651) 500-3650 for additional information.
    Full story
  • HealthSparq Launches New Solution to Address Provider Data Accuracy for a Better Consumer Experience

    Apr 4, 2023, 11:23 AM by
    HealthSparq, a Kyruus company, just launched a new solution, Validated Provider Profiles, to help health plans meet federal and state provider data requirements and improve the accuracy of member-facing directories.
    Full story
  • Report: Pillar VC and Pave Release Biotech Compensation Analysis

    Apr 4, 2023, 11:22 AM by
    3,700+ data points from biotech companies highlight salary ranges across job function and level
    Full story
  • Creative Proteomics Launches BioID Platform for Proximity-Dependent Biotin Identification

    Apr 4, 2023, 11:22 AM by
    Full story
  • Creative Proteomics Lipidomics Aids Environmental Microbial Community Studies with Phospholipid Fatty Acids Analysis Service

    Apr 4, 2023, 11:05 AM by
    Full story
  • Global Interoperability Leader Lyniate Rebrands as Rhapsody

    Apr 4, 2023, 11:04 AM by
    Full story
  • Abzena continues to add significant talent to its San Diego Biologics manufacturing facility

    Apr 4, 2023, 11:04 AM by
    Abzena, the leading end-to-end integrated CDMO for complex biologic molecules and Antibody Drug Conjugates (ADCs) has announced the appointment of Sean O’Brien as Senior Vice President and Site Head at its San Diego facility.
    Full story
  • ‘AMAR’ Is Latest Addition To The List Of Anti-Aging Hopefuls

    Apr 4, 2023, 01:00 AM by User Not Found
    Bio-IT World | Using “genetic trickery,” scientists at the University of Virginia (UVA) have hit on a means to detoxify the body of fat byproducts and, with that, extend the healthy lifespan of the model organism C. Elegans. The specific trick was to boost the activity of two enzymes involved in alcohol detoxification.
    Full story
  • Simplify Your Microbiome Research with MicrobioSeq’s Microbial Biomarker Discovery Service

    Apr 3, 2023, 11:20 AM by
    Full story
  • CD Genomics Unveils Advanced Mitochondrial Diseases Panel Sequencing Service

    Apr 3, 2023, 11:18 AM by
    Full story
  • CD Genomics Supports Immune and Cancer Research with TCR-Seq Service

    Apr 3, 2023, 11:15 AM by
    Full story
  • «
  • 111 (current)
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy